From staggering global usage and booming markets to groundbreaking medical applications and pressing health risks, the story of cannabis is a complex tapestry woven with statistics that demand a closer look.
Key Takeaways
- In 2022, approximately 52.5 million people aged 12 or older in the United States reported using cannabis in the past year, representing 18.7% of the population in that age group
- A 2023 study found that 22.0% of U.S. adults aged 18-25 used cannabis in the past month, the highest rate among age groups
- Globally, an estimated 219 million people used cannabis in 2022, making it the most widely used drug worldwide
- A clinical trial showed that cannabis with 10mg THC reduced chronic pain by 30% in 73% of patients vs placebo
- Epidiolex (CBD) reduced seizure frequency by 39% in Dravet syndrome patients in Phase 3 trials
- In a 2020 meta-analysis, medical cannabis reduced opioid use by 64% in chronic pain patients
- In 2023, U.S. cannabis sales reached $28.9 billion, up 10.4% from 2022
- Colorado collected $423 million in cannabis taxes in 2023, funding schools and infrastructure
- California's legal cannabis market generated $5.3 billion in 2023 sales
- As of 2024, 24 U.S. states have legalized recreational cannabis, covering 54% of population
- Canada fully legalized recreational cannabis on October 17, 2018, under Cannabis Act
- Uruguay became first country to legalize recreational cannabis in 2013
- Heavy cannabis use associated with 2.1-fold increased risk of schizophrenia in men
- Daily cannabis use linked to 34% higher risk of heart attack per 2024 study
- Adolescent cannabis use increases depression risk by 37% in adulthood
Cannabis is now widely used and studied for both its medical benefits and potential health risks.
Economic Aspects
1In 2023, U.S. cannabis sales reached $28.9 billion, up 10.4% from 2022
Verified2Colorado collected $423 million in cannabis taxes in 2023, funding schools and infrastructure
Verified3California's legal cannabis market generated $5.3 billion in 2023 sales
Verified4Global legal cannabis market projected to hit $57.2 billion by 2026, CAGR 24.3%
Directional5Canada’s legal cannabis sales were CAD 4.5 billion in 2023
Single source6U.S. cannabis industry employed 428,000 full-time workers in 2023
Verified7Illinois cannabis taxes yielded $1.5 billion since 2020 launch
Verified8Germany’s medical cannabis imports cost €1.2 billion in 2023
Verified9Michigan’s recreational cannabis sales hit $3.1 billion in 2023
Directional10Hemp-derived CBD market in U.S. valued at $5.3 billion in 2022
Single source11Nevada cannabis revenue topped $55 million monthly in 2023
Verified12Israel exported $500 million in medical cannabis products in 2023
Verified13Washington state cannabis taxes generated $466 million in 2023
Verified14U.S. ancillary cannabis businesses generated $2.5 billion in 2023
Directional15Oklahoma medical cannabis sales reached $1 billion in first year post-2018
Single source16Global cannabis beverage market expected to grow to $2.9 billion by 2028
Verified17Florida medical cannabis revenue was $1.8 billion in 2023
Verified18U.K. medical cannabis prescriptions rose 400% to 50,000 in 2023
Verified19Arizona recreational cannabis sales debuted with $30 million in first month 2021
Directional20In 2023, U.S. cannabis industry paid $3.5 billion in taxes
Single source21Oregon cannabis sales $1.7 billion since 2015
Verified22New Jersey first-year rec sales $700 million 2022
Verified23Global med cannabis market $14.9 billion in 2023
Verified24440,000 U.S. cannabis jobs projected by end 2023
Directional25New York rec sales $1.2 billion in first 2 years
Single source26Hemp fiber market $1.2 billion globally 2023
Verified27Connecticut cannabis taxes $250 million FY2023
Verified28Australia med cannabis $300 million AUD 2023
Verified29Virginia med sales $1 billion by 2023
Directional30Cannabis tourism generated $2 billion in Colorado 2023
Single source31Ohio med sales $400 million 2023
Verified32UK med cannabis market £100 million 2023
Verified33Massachusetts rec sales $5 billion cumulative 2016-2023
VerifiedEconomic Aspects Interpretation
While politicians continue to debate its merits, cannabis is quietly and profitably funding schools, creating jobs, and building economies with all the sober efficiency of a Fortune 500 company.
Health Benefits
1A clinical trial showed that cannabis with 10mg THC reduced chronic pain by 30% in 73% of patients vs placebo
Verified2Epidiolex (CBD) reduced seizure frequency by 39% in Dravet syndrome patients in Phase 3 trials
Verified3In a 2020 meta-analysis, medical cannabis reduced opioid use by 64% in chronic pain patients
Verified4Sativex (THC/CBD spray) improved spasticity scores by 20% in MS patients per 2019 review
Directional5Cannabis-based treatments alleviated chemotherapy-induced nausea in 70% of patients vs 10% placebo
Single source6A 2022 study found inhaled cannabis reduced PTSD symptoms by 50% in veterans over 8 weeks
Verified7CBD oil at 300mg daily reduced anxiety scores by 79% in 57 patients
Verified8Medical cannabis users reported 40% improvement in sleep quality in a 2021 Israeli study of 1,164 patients
Verified9In glaucoma patients, THC lowered intraocular pressure by 30-45% for 3-4 hours
Directional10Cannabis flower with 24% THC improved appetite by 75% in HIV/AIDS patients
Single source11A Phase 2 trial showed nabiximols reduced cancer pain by 1.37 points on NRS scale
Verified12In Crohn's disease, 10 patients achieved remission with inhaled cannabis vs 4 on placebo
Verified13Low-dose CBD (25mg) enhanced fear extinction in PTSD models by 65%
Verified14Medical cannabis reduced fibromyalgia pain by 2.5 points on VAS in 128 patients
Directional15THC:CBD 1:1 ratio improved bladder control in MS by 30%
Single source16In epilepsy, CBD adjunct therapy cut seizures by 50% in 43% of Lennox-Gastaut patients
Verified17Cannabis terpenes like myrcene enhanced anti-inflammatory effects by 40% in arthritis models
Verified18Vaping CBD reduced social anxiety by 60% in public speaking test
Verified19A randomized trial with 95 FM patients showed cannabis oil reduced pain by 1.7/10
Directional20In 128 cancer patients, MC improved sleep in 66% and appetite in 53%
Single source21THC/CBD oromucosal spray reduced MS spasticity by 0.8 points on 0-10 scale
Verified22In 30 HIV patients, dronabinol increased caloric intake by 600 kcal/day
Verified23CBD 600mg reduced anxiety in SAD patients during speech test
Verified24In 47 epilepsy patients, CBD reduced seizures by median 36.5%
Directional25Inhaled cannabis eased neuropathic pain by 3.3/10 reduction in 21 patients
Single source26MC registry data: 90% Parkinson's patients improved motor symptoms
Verified27Low-dose THC improved Alzheimer’s agitation in 9/10 patients
Verified28Cannabis reduced IBS symptoms in 50% of 19 patients over 8 weeks
VerifiedHealth Benefits Interpretation
While cannabis might still be fighting for its seat at the medical table, these statistics show it's not just pulling up a chair, but serving a full-course meal of symptom relief across a dozen debilitating conditions.
Legal and Policy
1As of 2024, 24 U.S. states have legalized recreational cannabis, covering 54% of population
Verified2Canada fully legalized recreational cannabis on October 17, 2018, under Cannabis Act
Verified3Uruguay became first country to legalize recreational cannabis in 2013
Verified4Germany legalized recreational cannabis possession up to 25g in public from April 2024
Directional5U.S. federal law still classifies cannabis as Schedule I under Controlled Substances Act
Single source6Malta legalized recreational cannabis clubs in 2021, allowing up to 500 members per club
Verified7Thailand decriminalized cannabis in June 2022, leading to 8,000+ dispensaries
Verified838 U.S. states allow medical cannabis as of 2024
Verified9Luxembourg legalized home cultivation of up to 4 plants per household in 2023
Directional10Mexico legalized recreational use up to 28g possession in June 2021
Single source11New Zealand rejected recreational legalization in 2020 referendum by 50.7%
Verified12Australia allows medical cannabis since 2016, but recreational illegal federally
Verified13U.K. rescheduled cannabis to Class B in 2009, medical access since 2018
Verified14Switzerland permits cannabis possession under 10g since 2013
Directional15Czech Republic allows home grow up to 5 plants since 2010
Single source16South Africa legalized private use and home grow up to 4 plants in 2018
Verified17U.S. DEA proposed rescheduling to Schedule III in May 2024
Verified18Brazil approved medical cannabis in 2015, first recreational bill in 2023
Verified19Netherlands tolerates sales up to 5g in coffeeshops since 1976
Directional20Spain medical cannabis bill passed 2022, coffeeshops tolerated
Single source21Georgia allows low-THC oil <5% since 2015
Verified22Jamaica decriminalized possession up to 2oz in 2015, Rastafari sacrament
Verified23Armenia legalized med cannabis 2023, first in region
Verified24Ohio legalized rec cannabis Issue 2 in Nov 2023
Directional25Kentucky med cannabis effective 2025 after 2023 law
Single source26Missouri legalized rec 2022, sales started Feb 2023
Verified27Philippines med cannabis pilot 2023 for 23 conditions
Verified28Colombia legalized med 2016, rec decrim 2023 SC ruling
Verified29Portugal decriminalized all drugs 2001, cannabis possession <25g admin offense
DirectionalLegal and Policy Interpretation
While the world increasingly embraces cannabis with a confusing patchwork of laws, the U.S. federal government stubbornly clings to its outdated Schedule I status, making the nation's stance look like a half-legalized, bureaucratic schizophrenic trying to give itself a pardon.
Prevalence and Usage
1In 2022, approximately 52.5 million people aged 12 or older in the United States reported using cannabis in the past year, representing 18.7% of the population in that age group
Verified2A 2023 study found that 22.0% of U.S. adults aged 18-25 used cannabis in the past month, the highest rate among age groups
Verified3Globally, an estimated 219 million people used cannabis in 2022, making it the most widely used drug worldwide
Verified4In Canada, cannabis use among young adults aged 20-24 reached 39% in the past year following legalization in 2018
Directional5The 2021 European Drug Report indicated that 8% of young adults (15-34) in the EU had used cannabis in the past year
Single source6In Australia, lifetime cannabis use among people aged 14+ was 31.6% in 2022-2023
Verified7U.S. past-month cannabis use among adults rose from 7.5% in 2015 to 15.3% in 2021
Verified8In 2023, 48% of New Zealand adults reported lifetime cannabis use
Verified9Among U.S. high school students, 15.8% reported past-year cannabis use in 2023, down from previous years
Directional10In the UK, 16.7% of adults aged 16-59 used cannabis in the last year per 2022 Crime Survey
Single source11Mexico saw 5.4% past-month cannabis use among adults in 2022
Verified12In 2021, 29.6 million Americans aged 12+ used cannabis in the past 30 days
Verified13Brazil's 2019 survey showed 8.4% lifetime prevalence among those 12-65
Verified14South Africa's 2019 data indicated 15% past-year use among 15-64 year olds
Directional15In Japan, lifetime cannabis use is only 1.8% due to strict laws, per 2020 survey
Single source16Germany's 2021 data showed 7.7% past-year use among 18-64 year olds
Verified17In 2023, 42% of U.S. college students reported lifetime cannabis use
Verified18Israel's medical cannabis patient registry grew to 130,000 by 2023
Verified19Past-day cannabis use in U.S. adults tripled from 0.9% in 2015 to 2.8% in 2022
Directional20In Uruguay, post-legalization, 16% of adults used cannabis in past year by 2022
Single source21Chronic daily cannabis use in U.S. adults reached 10.3 million in 2021
Verified22In 2022, 61.9 million Americans aged 12+ used cannabis past year, up from 47 million in 2019
Verified23Past 30-day use among U.S. 12th graders dropped to 15.8% in 2023
Verified24In Europe, 22 million used cannabis past year in 2022
Directional25Daily or near-daily use in U.S. adults reached 6.5 million in 2022
Single source26Women’s past-year cannabis use increased 4.3% to 19.6% from 2019-2022
Verified27In 2023, 28 states plus DC had recreational sales
Verified28Black Americans past-year use at 19.5% matching whites in 2022
Verified29Edible cannabis use past year 4.5 million U.S. adults 2021
Directional30Concentrate/dabs use past year 11% among young adults 2023
Single sourcePrevalence and Usage Interpretation
The world is lighting up more than a holiday fireworks display, with cannabis use now so widespread it's practically a global handshake, though the party favors—from gummies to dabs—and attendance rates vary dramatically by country, age, and law book.
Risks and Adverse Effects
1Heavy cannabis use associated with 2.1-fold increased risk of schizophrenia in men
Verified2Daily cannabis use linked to 34% higher risk of heart attack per 2024 study
Verified3Adolescent cannabis use increases depression risk by 37% in adulthood
Verified4THC impairs driving, doubling crash risk equivalent to 0.08% BAC alcohol
Directional5Cannabis use disorder affects 22-30% of users, per NIDA
Single source6Vaping cannabis causes EVALI in 2,800 cases with 68 deaths by 2020
Verified7Prenatal cannabis exposure linked to 2.4x low birth weight risk
Verified8Chronic use reduces lung function by 8% in FEV1 measures
Verified9High-potency cannabis (>10% THC) raises psychosis risk 5-fold
Directional10Emergency room visits for cannabis rose 15% annually 2015-2020
Single source11Cannabis smoke contains 20x more ammonia than tobacco smoke
Verified12Youth users show 8 IQ point decline persisting to adulthood
Verified13Cannabinoid hyperemesis syndrome cases increased 25x since 2000s
Verified14Mixing cannabis with tobacco raises dependence risk by 40%
Directional15Acute cannabis use impairs memory consolidation by 50% for 24 hours
Single source16Long-term use linked to gum disease in 3x more users
Verified17Pediatric cannabis ingestions via edibles rose 1500% 2017-2021
Verified18High-THC strains cause paranoia in 28% of users
Verified19Cannabis withdrawal symptoms affect 47% of daily users
Directional20Regular use increases testicular cancer risk by 20%
Single source21Cannabis use during pregnancy linked to 50% preterm birth increase
Verified22Daily use raises stroke risk 25% in young adults
Verified23Impaired cognition lasts 28 days post-abstinence in heavy users
Verified24Edible overdoses cause hospitalization in 1/6 child cases
Directional25Chronic bronchitis 20% higher in smokers
Single source26Psychotic episodes 4x more likely with daily high-potency use
Verified27Motivation syndrome in 34% young users
Verified28Tar in cannabis smoke 4x higher than tobacco per gram
Verified29Bipolar disorder risk doubles with adolescent onset use
Directional30CUD treatment success only 12% without intervention
Single sourceRisks and Adverse Effects Interpretation
The compiled statistics suggest that while cannabis may offer some a temporary escape, its heavy or chronic use systematically trades fleeting relief for a mounting ledger of mental, physical, and social debts that society and individuals are now being forced to pay, with interest.
Sources & References
- Reference 1SAMHSAsamhsa.govVisit source
- Reference 2NIDAnida.nih.govVisit source
- Reference 3UNODCunodc.orgVisit source
- Reference 4CANADAcanada.caVisit source
- Reference 5EMCDDAemcdda.europa.euVisit source
- Reference 6AIHWaihw.gov.auVisit source
- Reference 7CDCcdc.govVisit source
- Reference 8HEALTHhealth.govt.nzVisit source
- Reference 9GOVgov.ukVisit source
- Reference 10INEGIinegi.org.mxVisit source
- Reference 11IBGEibge.gov.brVisit source
- Reference 12SACENDIsacendi.gov.zaVisit source
- Reference 13NCDncd.mhlw.go.jpVisit source
- Reference 14DRUGCOMdrugcom.deVisit source
- Reference 15MONITORINGTHEFUTUREmonitoringthefuture.orgVisit source
- Reference 16TIMESOFISRAELtimesofisrael.comVisit source
- Reference 17JAMANETWORKjamanetwork.comVisit source
- Reference 18INEine.gub.uyVisit source
- Reference 19NIHnih.govVisit source
- Reference 20PUBMEDpubmed.ncbi.nlm.nih.govVisit source
- Reference 21FDAfda.govVisit source
- Reference 22NCBIncbi.nlm.nih.govVisit source
- Reference 23NEJMnejm.orgVisit source
- Reference 24MJBIZDAILYmjbizdaily.comVisit source
- Reference 25CDORcdor.colorado.govVisit source
- Reference 26CDPHcdph.ca.govVisit source
- Reference 27GRANDVIEWRESEARCHgrandviewresearch.comVisit source
- Reference 28LEAFLYleafly.comVisit source
- Reference 29CANNABIScannabis.illinois.govVisit source
- Reference 30BFARMbfarm.deVisit source
- Reference 31MICHIGANmichigan.govVisit source
- Reference 32STATISTAstatista.comVisit source
- Reference 33TAXtax.nv.govVisit source
- Reference 34LCBlcb.wa.govVisit source
- Reference 35NEWFRONTIERDATAnewfrontierdata.comVisit source
- Reference 36OKLAHOMAoklahoma.govVisit source
- Reference 37FORTUNEBUSINESSINSIGHTSfortunebusinessinsights.comVisit source
- Reference 38KNOWTHEFACTSMMJknowthefactsmmj.comVisit source
- Reference 39BBCbbc.comVisit source
- Reference 40DCCAdcca.az.govVisit source
- Reference 41DISAdisa.comVisit source
- Reference 42LAWS-LOISlaws-lois.justice.gc.caVisit source
- Reference 43BUNDESREGIERUNGbundesregierung.deVisit source
- Reference 44DEAdea.govVisit source
- Reference 45PULIZIJApulizija.gov.mtVisit source
- Reference 46FDAfda.moph.go.thVisit source
- Reference 47NCSLncsl.orgVisit source
- Reference 48GUICHETguichet.public.luVisit source
- Reference 49GOBgob.mxVisit source
- Reference 50ELECTIONSelections.nzVisit source
- Reference 51TGAtga.gov.auVisit source
- Reference 52BAGbag.admin.chVisit source
- Reference 53DROGY-INFOdrogy-info.czVisit source
- Reference 54GOVgov.zaVisit source
- Reference 55FEDERALREGISTERfederalregister.govVisit source
- Reference 56ANVISAanvisa.gov.brVisit source
- Reference 57ENGLISHenglish.rvo.nlVisit source
- Reference 58NHTSAnhtsa.govVisit source
- Reference 59MPPmpp.orgVisit source
- Reference 60OREGONoregon.govVisit source
- Reference 61NJnj.govVisit source
- Reference 62CANNABIScannabis.ny.govVisit source
- Reference 63MARKETSANDMARKETSmarketsandmarkets.comVisit source
- Reference 64PORTALportal.ct.govVisit source
- Reference 65VDHvdh.virginia.govVisit source
- Reference 66VISITCOLORADOvisitcolorado.comVisit source
- Reference 67OMMPS-OHIOommps-ohio.govVisit source
- Reference 68PROHIBITIONPARTNERSprohibitionpartners.comVisit source
- Reference 69MASSmass.govVisit source
- Reference 70BOEboe.esVisit source
- Reference 71DPHdph.georgia.govVisit source
- Reference 72MOJmoj.gov.jmVisit source
- Reference 73LOCloc.govVisit source
- Reference 74OHIOSOSohiosos.govVisit source
- Reference 75APPSapps.legislature.ky.govVisit source
- Reference 76HEALTHhealth.mo.govVisit source
- Reference 77PNApna.gov.phVisit source
- Reference 78CORTECONSTITUCIONALcorteconstitucional.gov.coVisit source
- Reference 79SICADsicad.ptVisit source
- Reference 80PEDIATRICSpediatrics.aappublications.orgVisit source